The life sciences practice at Baker McKenzie S.A.S. is lauded by clients for its ability to ‘anticipate regulatory changes and design preventive strategies’. The team acts for a broad base of multinational pharma, medical devices, cosmetics, and food and beverage companies, which it supports on a wide array of regulatory and sanitary law, IP, consumer protection and transactional matters. Juan Pablo Concha Delgado heads the life sciences, regulatory and patents department, and is recommended for providing ’tailored strategies’; he contributes experience in IP enforcement, market authorisations, pricing issues, advertising law and clinical trials, among others. Mid-level associate Andrés Hidalgo leads the pharmaceuticals and healthcare group, where he draws praise for his knowledge of the ‘subtleties and intricacies of the rules and issues’. In February 2024, associate Sara Merizalde moved in house at Baxter International. Since publication, Hidalgo has also left the firm - effective as of December 2025.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Baker McKenzie stands out for its expertise in IP and regulatory/health issues, offering sound and well-informed advice. The team is expert in analysing and managing relevant cases, and is at the forefront of new pronouncements from authorities. Lawyers provide specialised knowledge and a precise approach.’
- ‘Lawyers stand out for their knowledge of technical regulations and their ability to dynamically explain those to clients. They differentiate themselves from competitors by sending reports, updates, and other legally relevant information to their clients, keeping them informed of the latest trends.’
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Juan Pablo Concha